Hiroaki Ayabe

1.2k citations
6 papers · 534 · 1 hit paper · h-index 3

Impact in

  • Hepatology top 5%
    • Liver physiology and pathology
    • Single-cell and spatial transcriptomics
    • Pluripotent Stem Cells Research
    • Gene Regulatory Network Analysis
    • Gene expression and cancer classification
    • Renal and related cancers

Papers in

    • Pediatric Hepatobiliary Diseases and Treatments 2
    • Organ Transplantation Techniques and Outcomes 1
    • Pluripotent Stem Cells Research 1
    • Single-cell and spatial transcriptomics 1
    • Renal and related cancers 1

Hiroaki Ayabe

5 papers receiving 532 citations

Hiroaki Ayabe's Hit Papers

Multilineage communication regulates human liver bud development from pluripotency 2017 · 431 citations
4310+3+6Years since publication100200300400

Peers

Hiroaki Ayabe
Comparison fields: 5 of 68
  • Hepatology 118
  • Molecular Biology 326
  • Biophysics 24
  • Cancer Research 55
  • Surgery 132
Replace Lenka Belicová with:
Lenka Belicová United States
Antonio Lo Nigro Italy
Haiting Ma United States
Jennifer Axnick Germany
Shuyi Ji China
Uyunbilig Borjigin China
K. Tago Japan
Seigo Hatada United States
Mark Kalisz Denmark
Yosuke Ida Japan
Hiroaki Ayabe relative to Lenka Belicová United States Lenka Belicová's profile →
Citations per field
00.5×1.6×
Lenka Belicová · 1×
Citations per year

Countries citing papers authored by Hiroaki Ayabe

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Ayabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ayabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ayabe more than expected).

Fields of papers citing papers by Hiroaki Ayabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ayabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ayabe. The network helps show where Hiroaki Ayabe may publish in the future.

Co-authors

The 25 scholars most cited alongside Hiroaki Ayabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroaki Ayabe Line = papers co-authored together Hiroaki Ayabe links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Multilineage communication regulates human liver bud development from pluripotency
Hit paper breakdown →
2017431
2 202162
3 201839
4 20251
5
[Analysis of drug-induced apoptosis in human leukemic cell line (HL-60)].
19981
6 20250

About Hiroaki Ayabe

Hiroaki Ayabe is a scholar working on Surgery, Molecular Biology, Hepatology, Oncology and Cancer Research, having authored 6 papers that have together received 534 indexed citations. Recurring topics across this work include Liver physiology and pathology (3 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Pluripotent Stem Cells Research (1 paper), Single-cell and spatial transcriptomics (1 paper), Renal and related cancers (1 paper) and Organ Transplantation Techniques and Outcomes (1 paper). The work is most often cited by research in Hepatology (118 citations), Molecular Biology (326 citations), Biophysics (24 citations), Cancer Research (55 citations) and Surgery (132 citations). Hiroaki Ayabe has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Takanori Takebe, Hideki Taniguchi, J. Gray Camp, Emi Yoshizawa, Barbara Treutlein, Masaki Kimura, Keisuke Sekine, Ryo Okuda, Tobias Gerber and Sabina Kanton. Their work appears in journals such as Nature Communications, Molecular Therapy — Methods & Clinical Development, Hepatology, Stem Cell Reports and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact